Dr. Munshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E Superior Ave
Lurie 3-117
Chicago, IL 60611Phone+1 312-503-2301
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2002
University of WashingtonResidency, Internal Medicine, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
IL State Medical License 2000 - 2026
MI State Medical License 1999 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 1 citationsTrametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells.Thao D Pham, Anastasia E Metropulos, Nida Mubin, Jeffrey H Becker, Dhavan Shah
Molecular Cancer Therapeutics. 2024-12-03 - Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.Jeffrey H Becker, Anastasia E Metropulos, Christina Spaulding, Alejandra M Marinelarena, Mario A Shields
Cancer Research. 2024-11-04 - Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer.Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen, Hidayatullah G Munshi, Alicia Hulbert
Cancer Research Communications. 2024-08-01
Press Mentions
Combination Therapy May Improve Treatment Response in Pancreatic CancerOctober 10th, 2024- Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-ChiefDecember 14th, 2021
- Loss of Sirt2 Increases and Prolongs a Caerulein-Induced Pancreatitis Permissive Phenotype and Induces Spontaneous Oncogenic Kras Mutations in MiceNovember 7th, 2018
Grant Support
- Targeting Stromal Reaction In Pancreatic Cancer To Overcome Chemo-ResistanceVeterans Affairs2012
- Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2011–2012
- Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2008–2010
- Cadherin-Mediated Regulation Of MMPS In Oral CancerNational Cancer Institute2003–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
